As of November 2024, Seoulin Bioscience has a market cap of $42.05M. This makes Seoulin Bioscience the world's 26181th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $52.17M | 3.04% |
2023 | $50.63M | -19.14% |
2022 | $62.62M | -44.10% |
2021 | $112.01M | 62.71% |
2020 | $68.84M | 58.26% |
2019 | $43.50M | -8.77% |
2018 | $47.68M | -6.40% |
2017 | $50.94M | -18.25% |
2016 | $62.31M | 2.99% |
2015 | $60.50M | 97.34% |
2014 | $30.66M | -15.89% |
2013 | $36.45M | -17.32% |
2012 | $44.09M | - |